By Beatrice Nakibuuka
As Uganda and the world recover from the devastating impact of Covid-19, another virus, Human Metapneumovirus (hMPV) has emerged, raising global health concerns.
First identified in China, this respiratory virus is making headlines due to its rapid spread and potential to overwhelm healthcare systems.
Although hMPV was initially discovered in 2001, the recent outbreak features a more aggressive strain, sparking fears of another global health crisis. In response, health experts are sounding the alarm about its implications, particularly for vulnerable populations.
What is hMPV?
Human Metapneumovirus is a respiratory virus closely related to the Respiratory Syncytial Virus (RSV). Like RSV, it primarily targets the respiratory tract, causing symptoms ranging from mild colds to severe respiratory distress.
According to Dr Wei Zhang, a virologist at the Chinese Center for Disease Control and Prevention, the virus is particularly dangerous for young children, the elderly, and people with weakened immune systems. “What sets this new strain apart is its apparent ability to replicate more rapidly and cause severe lower respiratory infections,” Dr Zhang explained during a recent press briefing.
hMPV enters the body through the nose, mouth, or eyes, typically after inhaling droplets from an infected person coughing, sneezing, or breathing, or after touching contaminated surfaces.
After entering the body, the virus attaches to the epithelial cells lining the respiratory tract, which includes airways and the lungs.
These epithelial cells form a protective barrier in the airways, helping to guard the respiratory system while clearing mucus, dust, and other debris.
Once inside the cells, the virus replicates, producing more viral particles. These newly formed viruses infect neighbouring cells, spreading through the respiratory epithelium.
The body’s immune system detects the infection and launches an inflammatory response to combat the virus. While essential for clearing the virus, this reaction contributes to the symptoms of the infection, such as nasal congestion and a cough.
How it spreads
The virus is transmitted in much the same way as the flu and Covid-19—through respiratory droplets produced when an infected person coughs or sneezes. Coughing, sneezing, and close personal contact are all potential pathways for transmission. Unlike previous outbreaks, this strain of hMPV seems capable of surviving longer on surfaces, raising concerns about its ability to spread in crowded urban environments.
Reports from hospitals in Beijing, Shanghai, and other cities indicate a sharp rise in respiratory cases associated with hMPV. Although health authorities have yet to declare an emergency, the Chinese government has stepped up efforts to contain the outbreak, including imposing temporary lockdowns in affected regions.
While the outbreak remains contained to specific regions in China, the risk of international spread is significant, especially as global travel resumes.
Symptoms, signs
One of the challenges in controlling hMPV is its similarity to other respiratory illnesses. Symptoms include fever, persistent coughing, difficulty breathing, nasal congestion, and extreme fatigue.
In severe cases, patients have experienced pneumonia, bronchitis, and acute respiratory distress syndrome (ARDS). Medical professionals warn that the virus may present differently in vulnerable populations, with children more likely to develop wheezing and elderly patients at higher risk of respiratory failure.
hMPV is tested by collecting a sample of mucus from the nose or throat using a swab. Similar to Covid-19, the sample is analysed in a lab, often with RT-PCR tests. Other methods, like antigen tests, can also identify the virus.
The global concern
The emergence of hMPV in China has sparked fears of a global pandemic, particularly as international travel resumes at pre-Covid-19 levels. The World Health Organization (WHO) has urged countries to monitor for cases and strengthen surveillance efforts.
“hMPV is not a virus we can ignore,” Dr Maria Van Kerkhove, head of the WHO’s Emerging Diseases Unit said during a press conference organised by China’s National Institute for Communicable Disease Control and Prevention (China CDC). “While it has been circulating for decades, this particular strain demonstrates characteristics that could make it a more significant global health threat,” she added.
Experts are drawing comparisons to the early days of Covid-19, emphasising the need for swift action. Governments around the world are now focusing on improving diagnostic testing, increasing hospital preparedness, and accelerating vaccine research.
While the outbreak is still in its early stages, the WHO has warned that the virus could become a significant global health threat if not properly managed.
Uganda, like many other countries, must prepare to deal with a potential outbreak by strengthening its healthcare systems and promoting public awareness.
Dr Kerkhove emphasised the importance of monitoring and early containment. “hMPV is a virus we cannot afford to underestimate. Early detection and quick action will be crucial in preventing it from becoming a global crisis,” she stated.
While there is no specific vaccine or antiviral treatment for hMPV, scientists are working tirelessly to develop one. Researchers in China have already sequenced the genome of the new strain, a crucial first step in creating targeted therapies.
At the same press conference, Dr Li Ming, a vaccine researcher at Beijing’s Center for Infectious Disease Research, expressed cautious optimism. “Although hMPV poses a significant challenge, our experience with Covid-19 has equipped us with advanced tools to accelerate vaccine development. We now have tools and technologies that can shorten the time required to create effective vaccines,” he explained.
What Ugandans should know
Health experts are urging governments, including Uganda’s, to apply lessons from the Covid-19 pandemic to address this emerging threat. Early detection, effective containment, and public education remain the most effective strategies to prevent widespread transmission.
Uganda’s Ministry of Health is yet to release an official statement on hMPV, but experts recommend proactive measures, including enhanced surveillance and public health campaigns. By the time of publication, the ministry was hesitant to make conclusions and were still analysing the situation in China.
While there is no immediate threat to Uganda, citizens are encouraged to stay vigilant and prioritise preventive measures. Health experts recommend practicing frequent handwashing, wearing masks in crowded places, and disinfecting commonly touched surfaces to reduce the risk of infection.
Public health experts are urging nations to take proactive measures. Effective containment strategies, such as widespread testing, contact tracing, and public education, will be critical in controlling the spread of hMPV.
“Prevention is our best weapon right now,” Dr Zhang said. “Simple actions like wearing masks, practicing good hand hygiene, and avoiding crowded spaces can significantly reduce transmission. We all have a role to play in protecting ourselves and our communities,” he said at the China CDC press conference.
What you can do
Although the virus has yet to reach pandemic status, experts recommend staying informed and prepared. Keep an eye on updates from reliable health organisations, and take precautions to protect yourself and your family:
Practice frequent handwashing.
Wear masks in crowded or enclosed spaces.
Disinfect high-touch surfaces regularly.
Monitor symptoms and seek medical attention if needed.
Call for vigilance
The emergence of hMPV is a reminder of the unpredictable nature of infectious diseases. As Uganda focuses on bolstering its healthcare system and preparing for potential outbreaks, public cooperation will be critical in mitigating risks.
Whether hMPV becomes a global pandemic or remains a localized threat, the nation must stay ready. With swift action and collective effort, Uganda can protect its citizens and contribute to global efforts in combating this new viral challenge.
While anyone can catch hMPV, infants, older adults, and those with health conditions like immunosuppression, chronic obstructive pulmonary disease (COPD) and asthma are at higher risk for severe illness. Extra care should be taken to protect at-risk groups and health care workers from any respiratory infections.
